Durvalumab after chemoradiotherapy in patients with stage III non-small-cell lung cancer: real-world outcomes versus clinical trial results

Immunotherapy, Ahead of Print.

Source: Immunotherapy - June 9, 2023 Category: Allergy & Immunology Authors: Marjon V Verschueren Talitha Dijs Judith L Gulikers Ard van Veelen Sander Croes Lizza EL Hendriks Adrianus AJ Smit Lourens T Bloem Antoine CG Egberts Ewoudt MW van de Garde Bas JM Peters Source Type: research